Liver Disease
Liver disease can cause fatigue, abdominal discomfort, yellowing of the skin or eyes, and other symptoms that impact daily life. At CRP, we’re conducting clinical trials to evaluate new investigational treatments that may help support liver function and improve overall health. If you’ve been diagnosed with liver disease, you may be eligible to participate. Sign up to learn more and see if a study is right for you.
Get started now
Is an adult ≥18 years
Have diagnosis of MASLD at high risk, confirmed metabolic dysfunction–associated steatotic liver disease (MASLD)
May or may not have Type 2 Diabetes (T2D
Who is it for
This study evaluates whether once-weekly tirzepatide reduces the risk of major adverse liver outcomes (MALO) in adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Event-driven Phase 3 study with a meaningful, life-impacting endpoint: preventing cirrhosis, variceal bleeding, and liver failure.
About the Study
Benefits for participants
Access to tirzepatide, a promising therapy shown to:
Reduce liver fat, inflammation, and fibrosis
Improve weight loss and glycemic control
Improve lipids and metabolic health
Close medical monitoring and expert care
Potential to slow or prevent progression of serious liver disease
May receive reimbursement for time and travel
A guide to clinical trials
Sign up
Find a clinical trial that’s right for you or a loved one.
Pre Screen
We’ll check your health history to match you with the right trial.
Screening
Come to our clinic for tests and evaluations to confirm eligibility.
Join the Study
Once eligible, you’ll begin the trial and receive care based on the study plan.
